top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.755 +0.055 (+3.24%)
Streaming Delayed Price Updated: 1:07 PM EDT, May 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 258,836
Open 1.700
Bid (Size) 1.750 (2,700)
Ask (Size) 1.760 (10,700)
Prev. Close 1.700
Today's Range 1.690 - 1.760
52wk Range 1.330 - 2.260
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
-10.0%
-10.0%
1 Month
-7.1%
-7.1%
3 Month
-18.0%
-18.0%
6 Month
+14.0%
+14.0%
1 Year
-0.8%
-0.8%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.755
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 05/28/26 01:07 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 54.50M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 55M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
bottom of page